Q2 2025 featured flat turnover, 4% ARR growth, and a significant EBITDA decline due to increased investments and reorganization costs. New product launches and strategic acquisitions are underway, while no specific revenue guidance for 2026 is provided.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.